scorecardresearch
Monday, August 11, 2025
TopicBharat Biotech

Topic: Bharat Biotech

Bharat Biotech, IVI announce phase 2/3 clinical trial of Chikungunya vaccine in Costa Rica

Trials for the vaccine, which International Vaccine Institute is developing in partnership with Bharat Biotech, are also expected to begin in Panama and Colombia by September.

Covid vaccines for children could be available by September, Bharat Biotech & NIV say

Bharat Biotech CMD Dr Krishna Ella said final phase of clinical trial is over & they hope to get licence soon. NIV Director Dr Priya Abraham said vaccines may be available by Sept.

First nasal vaccine developed by Bharat Biotech gets nod for phase 2 trial

BBV154 is the first of its kind Covid-19 jab to undergo human clinical trials in India which is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine.

Every Covaxin batch undergoes over 200 tests, Bharat Biotech says over quality concerns

The statement from Hyderabad-based Covid vaccine manufacturer comes after reports surfaced claiming that Covaxin's test batches from the Bengaluru plant were not satisfactory.

Covaxin receives first Good Manufacturing Practice certificate in EU from Hungary

The approval came from the National Institute of Pharmacy and Nutrition Hungary and it marks the first compliance certificate received by Bharat Biotech from European regulators.

Brazil suspends decision to import 4 million doses of Bharat Biotech’s Covaxin

Brazil's decision came after Bharat Biotech terminated its pact with the country after its deal to supply 20 million Covaxin doses attracted investigation by Brazilian authorities.

How Brazil-Bharat Biotech deal for Covaxin crumbled in less than 30 days

The Jair Bolsonaro-led Brazil government cancelled Indian drugmaker Bharat Biotech’s emergency use authorisation request for its Covaxin vaccine on 24 July.

Brazil scraps Covaxin’s emergency use request after Bharat Biotech terminates vaccine pact

The termination came after the deal with the Brazilian Government for the supply of 20 million doses of the Covaxin landed in controversy and attracted investigation by authorities.

Bharat Biotech commits over 500 million doses of Covaxin to Centre

From January to 16 July, 54.5 million doses of Covaxin have been supplied to the government, MoS Health Bharati Pravin Pawar said in Parliament, earlier this week.

Assessing Covaxin data for emergency use listing, decision date yet to be confirmed: WHO

Suchitra Ella of Bharat Biotech said approval is not expected to be a long process as majority of Bharat Biotech's facilities have been audited and approved by WHO in the past.

On Camera

MBBS guidelines for students with disabilities reduce a life to a limb

The guidelines ask whether a student can climb stairs, but not whether the college has a ramp. They ask whether a student can bear weight, but not whether the system can bear the weight of its own prejudice.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

Legacy of Air Chief Marshal LM Katre, the man who flew Spitfires & ushered IAF into a modern era

ACM Katre was 2nd IAF chief to die in harness. It was at a memorial lecture in his honour where IAF chief AP Singh revealed that India shot down 6 Pakistani aircraft in Op Sindoor.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.